company-logo

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

OKYO Pharma Dividend Announcement

OKYO Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on OKYO Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

OKYO Pharma Dividend History

OKYO Pharma Dividend Yield

OKYO Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing OKYO Pharma stock? Use our calculator to estimate your expected dividend yield:

OKYO Pharma Financial Ratios

P/E ratio-1831.21
PEG ratio-69.47
P/B ratio-5.24
ROE0.42%
Payout ratio0.00%
Current ratio0.21
Quick ratio0.21
Cash Ratio0.11

OKYO Pharma Dividend FAQ

Does OKYO Pharma stock pay dividends?
OKYO Pharma does not currently pay dividends to its shareholders.
Has OKYO Pharma ever paid a dividend?
No, OKYO Pharma has no a history of paying dividends to its shareholders. OKYO Pharma is not known for its dividend payments.
Why doesn't OKYO Pharma pay dividends?
There are several potential reasons why OKYO Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will OKYO Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While OKYO Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is OKYO Pharma a dividend aristocrat?
OKYO Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is OKYO Pharma a dividend king?
OKYO Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is OKYO Pharma a dividend stock?
No, OKYO Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy OKYO Pharma stocks?
To buy OKYO Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy OKYO Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.